[IKT] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 3.12%
YoY- -0.54%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 116 65 123 0 7 46 2 1409.55%
PBT -5,778 -4,478 -4,279 -4,495 -4,640 -4,641 -5,042 9.53%
Tax 37 -474 -112 0 -4,640 -4,641 -0 -
NP -5,778 -4,003 -4,167 -4,495 -4,640 -4,641 -5,042 9.53%
Tax Rate - - - - - - - -
Total Cost 5,894 4,068 4,291 4,495 4,646 4,687 5,044 10.97%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -4,963.46 -6,204.86 -3,375.91 0.00 -70,817.14 -10,081.47 -259,342.54 -92.89%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.11 -0.87 -0.99 -1.06 -1.10 -1.10 -1.20 -5.07%
EPS Diluted -1.11 -0.87 -0.99 -1.06 -1.10 -1.10 -1.20 -5.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.